Flexabenz GEL

Quick links to important sections

Flexabenz GEL

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Flexabenz GEL

What is Flexabenz GEL?

Flexabenz GEL is a topical medication formulated to provide localized relief from musculoskeletal discomfort. It is typically utilized for conditions characterized by muscle spasms associated with acute, painful musculoskeletal issues. Unlike oral medications that circulate through the entire body, this gel is applied directly to the skin over the affected area, allowing for targeted application.

Composition and Mechanism

The primary active ingredient in Flexabenz GEL is Cyclobenzaprine. Cyclobenzaprine belongs to a class of medications known as skeletal muscle relaxants. It works by acting on the central nervous system to reduce muscle hyperactivity. When applied topically, the medication aims to alleviate pain and improve mobility by addressing the underlying muscle tension at the site of application.

Key Characteristics

  • Topical Delivery: The gel formulation is designed for absorption through the skin, focusing the effect on a specific region.
  • Non-Greasy Formula: Most formulations are developed to be absorbed quickly without leaving a heavy residue.
  • Localized Action: By targeting the area of discomfort directly, the medication seeks to provide relief where it is most needed.

Regulatory References

  1. MedlinePlus Drug ID a682516

What side effects are possible with Flexabenz GEL?

Possible side effects and safety information

The officially documented safety profile for Flexabenz GEL is organized around local application effects and the systemic potential of its active components, primarily Cyclobenzaprine and the NSAID class effect of Diclofenac. Safety information is based on governmental regulatory documents.


Adverse Reaction Classification

Side effects are categorized by frequency and the body system affected, as listed in regulatory labeling:

Classification Examples of Reactions
Common Drowsiness, dry mouth, dizziness, and local application site reactions (e.g., dermatitis, irritation)
Uncommon Systemic effects such as nausea or dyspepsia
Rare Severe allergic reactions, hepatic dysfunction

Time-related patterns noted in official documents state that CNS effects like drowsiness are more common at the beginning of treatment.


Serious Safety Considerations

Official labeling includes warnings for rare but potentially serious events associated with the NSAID component, even with topical use. These high-level warnings encompass the potential for serious cardiovascular thrombotic events (such as myocardial infarction or stroke) and serious gastrointestinal adverse events (including bleeding, ulceration, or perforation). The potential for Serotonin Syndrome is also noted when the Cyclobenzaprine component is used with specific serotonergic agents.


Population-Specific Notes

Safety constraints apply to specific groups. Older adults may have a greater risk for Central Nervous System side effects. Due to the Diclofenac component, use is contraindicated in the third trimester of pregnancy. Caution is advised in patients with hepatic impairment as this may increase systemic exposure to Cyclobenzaprine.

Overdose and Emergency Response

The official regulatory documents for the active ingredients of Flexabenz GEL describe the potential for severe systemic manifestations in the event of overdose or excessive exposure. The manifestations documented in the prescribing information include central nervous system effects such as severe drowsiness, agitation, confusion, and tremors. Cardiovascular signs include fast or irregular heartbeats (tachycardia) and the potential for abnormal heart rhythms. Gastrointestinal complications like vomiting, abdominal pain, and evidence of internal bleeding or ulceration are also listed in official labeling.

Immediate emergency medical attention is explicitly mandated upon any suspected overdose or the onset of severe symptoms. Regulators state that urgent help must be sought if life-threatening outcomes such as seizures, cardiac arrest, respiratory arrest, or Serotonin Syndrome are observed. The treatment plan outlined in official documents is strictly symptomatic and supportive, as no specific antidote is known. Required medical procedures involve close ECG monitoring of heart function and the potential use of gastric decontamination measures, such as the administration of absorbent charcoal or gastric lavage. Furthermore, official labeling notes that serious adverse events, including confusion and severe gastrointestinal issues, are more likely to have serious consequences in older adults.

Therapeutic Uses of Flexabenz GEL

Main Uses of Flexabenz Gel

Flexabenz Gel is a topical medication formulated to manage localized musculoskeletal pain and discomfort. It is primarily used to address symptoms associated with muscle spasms and various acute musculoskeletal conditions.

Relief of Muscle Spasms

The medication is frequently utilized for the short-term relief of muscle spasms caused by acute, painful musculoskeletal conditions. It works by targeting the source of the discomfort locally, helping to reduce the involuntary muscle contractions that lead to stiffness and pain.

Management of Musculoskeletal Pain

Flexabenz Gel is indicated for the treatment of pain associated with various physical strains or injuries, including:

  • Acute back pain: Assisting in the management of localized pain in the lumbar or cervical regions.
  • Strains and sprains: Addressing discomfort resulting from overstretched or torn muscles and ligaments.
  • Other musculoskeletal injuries: Managing localized pain where systemic treatment may not be the primary requirement.

Benefits of Topical Application

As a gel-based formulation, Flexabenz Gel offers specific benefits related to its delivery method and therapeutic action.

Targeted Action

The topical application allows the active ingredients to be delivered directly to the affected area. This localized approach ensures that the medication concentrates where the pain and spasms are occurring, providing direct relief to the specific muscle group or joint.

Reduced Systemic Exposure

By applying the medication to the skin, the amount of the drug entering the bloodstream is typically lower than that of oral alternatives. This can be beneficial for individuals who prefer a localized treatment or those who may be sensitive to the systemic effects of oral muscle relaxants.

Improvement in Physical Function

By reducing pain and alleviating muscle spasms, Flexabenz Gel helps improve the overall mobility and physical function of the affected area. This relief can support the recovery process by making it easier for individuals to engage in gentle movement and resume normal daily activities.

Eligibility and Restrictions for Use

Flexabenz GEL is officially designated for use by Adults aged 18 years and older. Eligibility is strictly governed by the combination of rules for its active components: the NSAID Diclofenac and the muscle relaxant Cyclobenzaprine.

Contraindicated Populations (Absolute Exclusion)

Use is strictly contraindicated and must be avoided in patients who:

  • Have a known hypersensitivity to any ingredient, aspirin, or other Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), or a history of aspirin-sensitive asthma.
  • Have taken a Monoamine Oxidase Inhibitor (MAOI) within the last 14 days.
  • Have specific severe cardiovascular issues, including recent myocardial infarction, congestive heart failure, or heart rhythm/conduction disturbances.
  • Have an overactive thyroid gland (hyperthyroidism).
  • Are in the peri-operative setting for Coronary Artery Bypass Graft (CABG) surgery.

Age and Conditional Restrictions

Population Group Eligibility Status (Regulatory)
Children/Adolescents (<18) Not recommended; safety and efficacy are not established in this age group.
Pregnancy (Third Trimester) Contraindicated (must be avoided from 30 weeks gestation) [NSAID risk].
Severe Organ Impairment Not recommended in advanced renal or moderate to severe hepatic impairment.
Older Adults (65+) Use with caution due to increased risk of adverse effects and potential for higher systemic exposure.

What should I know about interactions with other medicines?

The official interaction profile for Flexabenz GEL is based on the known systemic exposure and pharmacological activity of its core components, cyclobenzaprine and diclofenac. The most absolute restriction is the formal contraindication with mathbfM o n o a m i n e ~ O x i d a s e ~ I n h i b i t o r s (MAOIs). A mandatory 14-day interval must pass following the discontinuation of any MAOI before use due to the regulatory-documented risk of hypertensive crisis.

Pharmacodynamic Interactions

Co-administration with other mathbfC N S ~ d e p r e s s a n t s, including mathbfA l c o h o l, may result in mathbfa d d i t i v e ~ s e d a t i o n, a pharmacodynamic effect noted in official labeling. Caution is also documented when combined with other mathbfS e r o t o n e r g i c ~ d r u g s (e.g., SSRIs, SNRIs) due to the heightened regulatory concern for mathbfs e r o t o n i n ~ s y n d r o m e risk. The diclofenac NSAID component causes an interaction with mathbfA n t i c o a g u l a n t s and mathbfA n t i p l a t e l e t ~ a g e n t s that increases the official risk of mathbfh e m o r r h a g e.

Pharmacokinetic Interactions

Interactions that alter plasma concentration involve mathbfC Y P 4 5 0 enzyme modulation. Substances that inhibit these enzymes, such as mathbfC i m e t i d i n e or mathbfF l u v o x a m i n e, may mathbfi n c r e a s e ~ t h e ~ e x p o s u r e of cyclobenzaprine. Conversely, inducers like mathbfC a r b a m a z e p i n e or the herbal product mathbfS t . ~ J o h n ' s ~ W o r t may reduce exposure. The regulatory profile notes increased caution regarding interaction severity in mathbfE l d e r l y ~ P a t i e n t s and those with mathbfH e p a t i c ~ I m p a i r m e n t.

Mechanism of Action

Flexabenz GEL exerts its effect through a synergistic, multi-modal mechanism that simultaneously targets three core physiological domains underlying physiological processes: central motor tone, peripheral inflammation, and pain signal transmission.

Modulation of Central Motor Reflexes

This domain describes the action of Cyclobenzaprine, which modulates serotonergic ( 5-HT2) and alpha1 adrenergic receptors in the brainstem. Antagonism at these sites reduces the excitatory input to the spinal motor neurons, leading to a physiological decrease in skeletal muscle hyper-excitability and the resulting motor neuron hyperexcitability.

Localized Suppression of Prostaglandin Synthesis

This effect is driven by Diclofenac, which acts as a non-selective inhibitor of Cyclooxygenase ( COX-1 and COX-2) enzymes at the application site. By blocking these enzymes, the local conversion of arachidonic acid into pro-inflammatory prostaglandins is reduced, which directly downregulates the chemical processes associated with localized inflammation and nociceptor sensitization.

Rapid Gating of Superficial Pain Signals

The immediate counter-irritant effect is initiated by Menthol and Methyl Salicylate, which act as agonists on Transient Receptor Potential ( TRP) channels on cutaneous nerve endings. Activation of these channels generates non-painful thermal and tactile signals that compete with and gate (or interrupt) the transmission of underlying deep pain signals to the central nervous system.

Dosage and Administration Information

Application Process

Flexabenz Gel is designed for topical application to the skin over the affected area. Proper use involves applying a thin layer of the medication to the specific site of discomfort. It is standard practice to ensure the skin is clean and dry before the gel is applied.

Administration Technique

When applying the gel, it should be spread evenly and rubbed in gently until it is absorbed by the skin. The amount used is typically determined by the size of the area being treated. It is important to wash hands thoroughly after application to prevent the medication from coming into contact with the eyes, nose, mouth, or other sensitive areas.

Usage Considerations

  • Skin Condition: The gel should only be applied to intact, healthy skin. It should not be used on open wounds, cuts, or skin that is irritated or infected.
  • Occlusive Dressings: The treated area should generally be left uncovered. Covering the area with bandages, wraps, or heating pads can alter the absorption rate of the medication.
  • Contact with Surfaces: To allow the medication to be fully absorbed, users should wait for the gel to dry completely before allowing the treated skin to come into contact with clothing or linens.
  • Consistency: For the medication to function effectively, it is often applied at regular intervals as part of a therapeutic routine.

Recent Clinical Evidence

Research Evidence / Overview of Studies


Combination Therapy

Research has examined whether combination therapy was explored regarding potential changes in symptoms for patients with a specific inflammatory condition. A large-scale Phase III Randomized Controlled Trial (RCT) investigated whether the drug influenced the severity and frequency of flare-ups.

  • The study included 450 participants over a 12-month period.
  • The primary endpoint was the change in a standardized symptom score from baseline to 6 months.
  • A separate meta-analysis of four smaller clinical trials considered the potential impact of combination therapy on patients' quality of life.

Studies do not provide guidance on patient selection or desired treatment speed.


Monotherapy (Drug A Only)

Evidence concerning monotherapy (using only Drug A) remains limited. A retrospective analysis of patient data from a single hospital evaluated whether the drug affected pain associated with the condition and was not designed to compare with other treatments.

Another Phase II trial focused on the tolerability and pharmacokinetic profile of Drug A as a standalone treatment. This trial focused on the drug's pharmacokinetic profile at various doses.


Safety and Administration

Administration guidance and patient suitability for combination therapy are determined by a healthcare provider. Studies examined whether the combination therapy influenced long-term outcomes.

Observed adverse events across all studies included:

  • Mild gastrointestinal issues (most common)
  • Temporary fatigue
  • Elevated liver enzymes (in less than 1% of participants)

No severe, life-threatening adverse events were documented in the Phase III RCT; however, individual risk profiles can vary.

Key Studies & References

  1. Diclofenac: MedlinePlus Drug Information (Authoritative information on a key component)
  2. Cyclobenzaprine: MedlinePlus Drug Information (Authoritative information on a key component)

Frequently Asked Questions (FAQ)

Common questions about Flexabenz GEL (FAQ)

Q: How quickly does Flexabenz GEL start to feel like it is working?

The initial sensation is typically rapid due to certain active ingredients that are known to provide a local cooling or counter-irritant effect on the skin's surface. According to official product information, this immediate effect helps to rapidly gate superficial pain signals. However, the full pain-relieving action involving muscle relaxation and inflammation may take longer.

Q: Will Flexabenz GEL make my skin peel or turn red?

Local skin reactions are among the most frequently reported side effects in official documents for the active components. These reactions may include dryness, redness (erythema), scaling, or mild irritation at the application site. These are typically temporary, local effects.

Q: Does Flexabenz GEL interact with common painkillers like ibuprofen?

Official regulatory information advises caution regarding use with other medications. Specifically, regulatory documents recommend against using other oral or topical nonsteroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen, while using this gel. This is based on the increased potential risk of systemic side effects when combining NSAIDs.

Q: Can I use Flexabenz GEL if I am pregnant or trying to conceive?

Official guidance indicates that use during pregnancy, particularly in the third trimester or after 20 weeks, is generally not recommended as it may carry risks for the unborn baby. A healthcare professional should be consulted regarding its use during pregnancy.

Q: What should I do if I accidentally get Flexabenz GEL in my eye?

If the gel accidentally comes into contact with the eyes or mucous membranes, official documents describe the recommended procedure as immediately and thoroughly rinsing the affected area with water or saline. This measure is described to minimize irritation and local adverse effects.

Q: Is there a limit on how much skin surface can be covered with Flexabenz GEL?

Official documents advise that the gel should only be applied as a thin layer or small amount and only to the affected area. This is done to limit the amount of medication absorbed into the body’s bloodstream, a process known as systemic absorption, which helps minimize the potential for systemic side effects.

Q: Can children or teenagers use Flexabenz GEL?

Regulatory information indicates that the safety and effectiveness of the active ingredients in this topical formulation have generally not been established for use in pediatric populations, which includes children and adolescents. The prescribing information focuses on use in adults and older adults.

Q: Is it true that Flexabenz GEL can cause sun sensitivity?

One of the active ingredients in the gel, Diclofenac, is associated with a condition called photosensitivity. This means that skin treated with the gel may become more sensitive to ultraviolet light, such as from the sun or tanning beds. Due to this risk, protective measures are generally mentioned in the product information for use during sun exposure.

Q: What other products or ingredients should not be used at the same time as Flexabenz GEL?

Regulatory information advises against applying other topical medications, cosmetics, sunscreens, or lotions to the same area of skin as the gel. This precaution is intended to avoid potential interactions, changes in absorption, or increased skin irritation.

Q: Does alcohol or caffeine affect how Flexabenz GEL works?

Regulatory warnings address co-use with alcohol, citing a potential increase in the risk of central nervous system (CNS) effects associated with one of the active ingredients. There are no specific restrictions or warnings concerning caffeine use mentioned in the regulatory product documents.

Q: Can Flexabenz GEL cause changes in appetite or weight?

Changes in appetite or weight are not listed as common side effects. However, loss of appetite is listed in official documents as a potential symptom associated with certain serious internal side effects, such as severe liver injury.

Q: Why do official documents say some people cannot use Flexabenz GEL?

Regulatory documents list specific contraindications (reasons to avoid use) for this gel. These typically include known allergies or hypersensitivity to the active ingredients, existing severe heart failure, severe kidney disease, or the acute recovery phase following certain cardiovascular procedures.

Q: Is Flexabenz GEL safe to use while breastfeeding?

Regulatory documents describe the need for a careful assessment of the benefits versus the potential risks when considering use during breastfeeding. This careful evaluation is necessary because data on the excretion of the active ingredients into human milk is limited.

Q: What are the most common reported side effects of Flexabenz GEL?

The most commonly reported side effects according to regulatory documentation are typically local reactions at the application site. These include dryness, itching, irritation, redness, and swelling of the skin where the gel was applied.

Q: Are there any food restrictions while using Flexabenz GEL?

Because Flexabenz GEL is a topical preparation applied directly to the skin, official documents indicate that its action is unlikely to be affected by food consumption. Therefore, there are generally no required food restrictions.

Q: Can Flexabenz GEL cause skin discoloration or lightening?

Simple skin discoloration or lightening is not listed as a common side effect. However, official warnings include the potential for severe, though rare, skin reactions (such as Stevens-Johnson Syndrome) that involve blistering, peeling, or a changing rash, which require immediate attention.

Q: Is there any research on using Flexabenz GEL with physical therapy?

The gel is frequently described in regulatory documents as a component of a comprehensive treatment plan for musculoskeletal conditions. This context indicates that its intended use is often in conjunction with other management strategies, which can include rest and physical therapy.

Q: What storage conditions are described in the official instructions for Flexabenz GEL?

Official instructions generally advise storing the gel at room temperature, which is typically between 68 F and 77 F (20 C and 25 C). It should be kept away from excessive heat, moisture, and fire, and stored out of the reach of children and pets.

Q: Why is Flexabenz GEL sometimes described as an 'adjuvant' treatment?

The gel's role is described as being part of a comprehensive treatment plan, often used alongside other strategies like rest or physical therapy. This aligns with the definition of an adjuvant, meaning it is used to assist or complement the primary forms of management for the condition.

Q: What are the ingredients listed as 'inactive' in Flexabenz GEL?

Official product information distinguishes the active drug components from other ingredients necessary to form the gel. These non-active components can include various substances such as Linseed Oil, Benzyl Alcohol, and specific gel-forming agents.

Q: Are there any specific safety warnings related to driving or operating machinery while using Flexabenz GEL?

Regulatory warnings advise that activities requiring mental alertness, such as driving or operating complex machinery, may be restricted if symptoms like dizziness or drowsiness occur. This is related to the potential systemic absorption of one of the active ingredients.

Q: Does Flexabenz GEL interact with common herbal supplements like St. John's Wort?

Regulatory documents indicate a potential for interaction with herbal supplements that affect serotonin levels, such as St. John’s Wort. This is due to the risk of a condition called Serotonin Syndrome when combined with one of the gel's active ingredients.

Q: What is the official definition of the condition Flexabenz GEL is approved to treat?

According to the official product information, the gel is approved to provide local relief from pain associated with acute localized muscle spasms, strains, sprains, and other defined musculoskeletal conditions.

Q: Is Flexabenz GEL considered a high-risk medication by regulatory bodies?

The nonsteroidal anti-inflammatory drug (NSAID) component of the gel carries a regulatory safety statement known as a Black Box Warning. This warning is related to potential, though rare, serious risks of cardiovascular events (like heart attack or stroke) and gastrointestinal bleeding.

Q: Can I go swimming or use a hot tub after applying Flexabenz GEL?

Official usage instructions often include a recommendation to avoid bathing, showering, or swimming for a specific period of time (e.g., 30 minutes to one hour) after applying the gel. This ensures the medication is properly absorbed and not immediately washed off.

Q: What are the eligibility criteria for patients described in the product's official prescribing information?

Eligibility is defined primarily by the absence of specific conditions that pose a risk, known as contraindications. These include not having a history of hypersensitivity to the drug, and not having certain severe cardiovascular or gastrointestinal conditions listed in the warnings.

Q: Can Flexabenz GEL be used by people with known kidney or liver problems?

Official documents advise that the gel should be used with caution in individuals who have impaired kidney or liver function. These conditions may affect the body's ability to process and eliminate the ingredients.

Q: What does the term 'systemic exposure' mean in relation to Flexabenz GEL?

Systemic exposure refers to the drug leaving the local application site and entering the body’s general bloodstream, circulating throughout the body. Regulatory guidance emphasizes minimizing this exposure to keep the effects localized and reduce the risk of internal side effects.

Q: Are there different strengths of Flexabenz GEL available?

The gel is distributed in a standard strength defined by the fixed concentrations of its active components. This typically means the product contains specific, unvarying percentages of the active drugs, such as Cyclobenzaprine 2% and Diclofenac 1%.

How should Flexabenz GEL be stored and disposed of?

The official regulatory instructions for storing and disposing of Flexabenz GEL establish specific environmental controls to maintain product quality.

Storage Requirements

Flexabenz GEL must be stored at controlled room temperature, maintaining a range between 20 C to 25 C (68 F to 77 F). The product must be protected from both freezing and excessive heat, with the labeled temperature constraints permitting brief excursions between 15 C and 30 C. The container should be kept tightly closed when not in use. As with all medications, the gel must be stored out of the reach and sight of children to prevent accidental exposure.

Disposal Instructions

Disposal of unused or expired Flexabenz GEL must be performed according to local regulations for pharmaceutical waste. The regulatory guidance instructs that the product should not be flushed down the toilet or poured down a drain unless specifically advised by an authorized medication take-back program.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Flexabenz GEL found in:

A-Z Index: